These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 10506868

  • 21. [Difluoroquinolone lomefloxacin (Maxaquin): its role among fluoroquinolones, possibilities and prospectives].
    Padeĭskaia EN.
    Antibiot Khimioter; 1998; 43(10):4-9. PubMed ID: 9825101
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Review [new antimicrobial agent series XLI]: lomefloxacin].
    Soejima R, Matsumoto F.
    Jpn J Antibiot; 1991 Oct; 44(10):1045-60. PubMed ID: 1662290
    [No Abstract] [Full Text] [Related]

  • 24. [The possibility of drug design of quinolones effective for multiresistant gram-positive pathogens].
    Hayakawa I.
    Nihon Rinsho; 1997 May; 55(5):1266-71. PubMed ID: 9155185
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antimicrobial activity of E-4441, a representative azetidine quinolone.
    Esteve M, Moros M, Coll R, Xicota MA, Llovera S.
    Drugs Exp Clin Res; 1990 May; 16(9):445-9. PubMed ID: 2100245
    [Abstract] [Full Text] [Related]

  • 28. [In vitro evaluation of lomefloxacin].
    Dette GA, Knothe H.
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria.
    Poole K.
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2595-9. PubMed ID: 10991829
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Sparfloxacin in the treatment of males with urethritis.
    Tanaka M, Matsumoto T, Kumazawa J, Nagayama A.
    Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):660. PubMed ID: 1327790
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Gram-positive infections and quinolones in neutropenia.
    Castagnola E, Viscoli C.
    Ann Intern Med; 1997 May 15; 126(10):830-1. PubMed ID: 9148666
    [No Abstract] [Full Text] [Related]

  • 38. Use of newer quinolones for the treatment of intraabdominal infections: focus on clinafloxacin.
    Nord CE.
    Infection; 1999 May 15; 27(3):166-72. PubMed ID: 10378126
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. 4th International Symposium on New Quinolones. Proceedings. Munich, Germany, August 27-29, 1992.
    Drugs; 1993 May 15; 45 Suppl 3():1-475. PubMed ID: 7689438
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.